Accelerate Diagnostics, Inc. (AXDX)
USD 0.7
(-0.71%)
USD 0.7
(-0.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.55 Million USD | -22.8% |
| 2022 | 3.3 Million USD | 966.93% |
| 2021 | -381 Thousand USD | -108.54% |
| 2020 | 4.45 Million USD | 1.34% |
| 2019 | 4.4 Million USD | 77.2% |
| 2018 | 2.48 Million USD | -21.8% |
| 2017 | 3.17 Million USD | 1190.65% |
| 2016 | 246 Thousand USD | 67.35% |
| 2015 | 147 Thousand USD | 20.49% |
| 2014 | 122 Thousand USD | 152.67% |
| 2013 | 48.28 Thousand USD | -79.54% |
| 2012 | 236 Thousand USD | -78.95% |
| 2011 | 1.12 Million USD | -50.07% |
| 2010 | 2.24 Million USD | 76.84% |
| 2009 | 1.26 Million USD | 172.58% |
| 2008 | 465.87 Thousand USD | 268.32% |
| 2007 | 126.48 Thousand USD | -26.07% |
| 2006 | 171.09 Thousand USD | -50.64% |
| 2005 | 346.6 Thousand USD | 554.16% |
| 2004 | 52.98 Thousand USD | -92.45% |
| 2003 | 702.03 Thousand USD | 49.45% |
| 2002 | 469.73 Thousand USD | 46.32% |
| 2001 | 321.02 Thousand USD | -65.23% |
| 2000 | 923.37 Thousand USD | -44.69% |
| 1999 | 1.66 Million USD | -73.2% |
| 1998 | 6.22 Million USD | 183.09% |
| 1997 | 2.2 Million USD | 22.22% |
| 1996 | 1.8 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 723 Thousand USD | 19.31% |
| 2024 Q2 | 676 Thousand USD | -6.5% |
| 2023 FY | 2.55 Million USD | -22.8% |
| 2023 Q1 | 1.01 Million USD | 55.54% |
| 2023 Q3 | 107 Thousand USD | -86.61% |
| 2023 Q4 | 606 Thousand USD | 466.36% |
| 2023 Q2 | 799 Thousand USD | -20.97% |
| 2022 FY | 3.3 Million USD | 966.93% |
| 2022 Q4 | 650 Thousand USD | -15.58% |
| 2022 Q3 | 770 Thousand USD | -28.7% |
| 2022 Q1 | 802 Thousand USD | 124.17% |
| 2022 Q2 | 1.08 Million USD | 34.66% |
| 2021 Q1 | 897 Thousand USD | -21.86% |
| 2021 FY | -381 Thousand USD | -108.54% |
| 2021 Q2 | 1.05 Million USD | 17.39% |
| 2021 Q4 | -3.31 Million USD | -436.51% |
| 2021 Q3 | 986 Thousand USD | -6.36% |
| 2020 Q3 | 1.3 Million USD | 36.37% |
| 2020 Q4 | 1.14 Million USD | -11.76% |
| 2020 FY | 4.45 Million USD | 1.34% |
| 2020 Q1 | 1.05 Million USD | -30.27% |
| 2020 Q2 | 954 Thousand USD | -9.57% |
| 2019 Q2 | 899 Thousand USD | 7.79% |
| 2019 Q3 | 1.15 Million USD | 28.36% |
| 2019 Q1 | 834 Thousand USD | 59.16% |
| 2019 FY | 4.4 Million USD | 77.2% |
| 2019 Q4 | 1.51 Million USD | 31.11% |
| 2018 Q2 | 975 Thousand USD | 215.53% |
| 2018 FY | 2.48 Million USD | -21.8% |
| 2018 Q4 | 524 Thousand USD | -22.37% |
| 2018 Q3 | 675 Thousand USD | -30.77% |
| 2018 Q1 | 309 Thousand USD | -78.97% |
| 2017 Q1 | 504 Thousand USD | 1192.31% |
| 2017 Q2 | 564 Thousand USD | 11.9% |
| 2017 Q3 | 637 Thousand USD | 12.94% |
| 2017 Q4 | 1.46 Million USD | 130.61% |
| 2017 FY | 3.17 Million USD | 1190.65% |
| 2016 Q1 | 163 Thousand USD | 640.91% |
| 2016 Q4 | 39 Thousand USD | 62.5% |
| 2016 Q2 | 20 Thousand USD | -87.73% |
| 2016 Q3 | 24 Thousand USD | 20.0% |
| 2016 FY | 246 Thousand USD | 67.35% |
| 2015 Q3 | 92 Thousand USD | 384.21% |
| 2015 Q4 | 22 Thousand USD | -76.09% |
| 2015 FY | 147 Thousand USD | 20.49% |
| 2015 Q1 | 14 Thousand USD | -82.28% |
| 2015 Q2 | 19 Thousand USD | 35.71% |
| 2014 Q1 | 14 Thousand USD | 12.57% |
| 2014 Q4 | 79 Thousand USD | 393.75% |
| 2014 Q3 | 16 Thousand USD | 23.08% |
| 2014 FY | 122 Thousand USD | 152.67% |
| 2014 Q2 | 13 Thousand USD | -7.14% |
| 2013 Q2 | 7373.00 USD | -52.97% |
| 2013 Q3 | 12.79 Thousand USD | 73.57% |
| 2013 FY | 48.28 Thousand USD | -79.54% |
| 2013 Q4 | 12.43 Thousand USD | -2.81% |
| 2013 Q1 | 15.67 Thousand USD | 186.3% |
| 2012 Q2 | 12.45 Thousand USD | -5.68% |
| 2012 Q3 | 8304.00 USD | -33.34% |
| 2012 FY | 236 Thousand USD | -78.95% |
| 2012 Q4 | 5476.00 USD | -34.06% |
| 2012 Q1 | 13.2 Thousand USD | 58.59% |
| 2011 FY | 1.12 Million USD | -50.07% |
| 2011 Q4 | 8328.00 USD | -95.88% |
| 2011 Q2 | 100.96 Thousand USD | -57.98% |
| 2011 Q1 | 240.27 Thousand USD | -23.37% |
| 2011 Q3 | 202 Thousand USD | 100.08% |
| 2010 Q2 | 2.16 Million USD | 10770.08% |
| 2010 Q4 | 313.56 Thousand USD | -32.76% |
| 2010 Q3 | 466.36 Thousand USD | -78.41% |
| 2010 FY | 2.24 Million USD | 76.84% |
| 2010 Q1 | 19.87 Thousand USD | -60.25% |
| 2009 Q4 | 49.99 Thousand USD | 221.53% |
| 2009 FY | 1.26 Million USD | 172.58% |
| 2009 Q1 | 278.52 Thousand USD | -23.59% |
| 2009 Q2 | 326.21 Thousand USD | 17.12% |
| 2009 Q3 | 15.54 Thousand USD | -95.23% |
| 2008 Q3 | 300.65 Thousand USD | 39.9% |
| 2008 Q1 | 60.89 Thousand USD | -51.97% |
| 2008 FY | 465.87 Thousand USD | 268.32% |
| 2008 Q4 | 364.49 Thousand USD | 21.23% |
| 2008 Q2 | 214.9 Thousand USD | 252.91% |
| 2007 Q1 | 18.65 Thousand USD | -77.53% |
| 2007 Q3 | 63.27 Thousand USD | 377.38% |
| 2007 Q2 | -22.81 Thousand USD | -222.29% |
| 2007 FY | 126.48 Thousand USD | -26.07% |
| 2007 Q4 | 126.79 Thousand USD | 100.4% |
| 2006 Q4 | 83 Thousand USD | 74.23% |
| 2006 Q3 | 47.63 Thousand USD | 12.26% |
| 2006 Q2 | 42.43 Thousand USD | 183.25% |
| 2006 Q1 | 14.98 Thousand USD | -63.62% |
| 2006 FY | 171.09 Thousand USD | -50.64% |
| 2005 Q2 | 67.45 Thousand USD | -4.49% |
| 2005 Q3 | 72.49 Thousand USD | 7.48% |
| 2005 Q1 | 70.62 Thousand USD | -66.24% |
| 2005 FY | 346.6 Thousand USD | 554.16% |
| 2005 Q4 | 41.18 Thousand USD | -43.19% |
| 2004 Q2 | -247.3 Thousand USD | -358.65% |
| 2004 Q4 | 209.17 Thousand USD | 1768.63% |
| 2004 Q1 | 95.61 Thousand USD | -9.75% |
| 2004 Q3 | 11.19 Thousand USD | 104.53% |
| 2004 FY | 52.98 Thousand USD | -92.45% |
| 2003 Q2 | 150.82 Thousand USD | -31.18% |
| 2003 FY | 702.03 Thousand USD | 49.45% |
| 2003 Q1 | 219.14 Thousand USD | 20.4% |
| 2003 Q3 | 98.73 Thousand USD | -34.54% |
| 2003 Q4 | 105.94 Thousand USD | 7.31% |
| 2002 Q1 | 85.44 Thousand USD | -37.04% |
| 2002 FY | 469.73 Thousand USD | 46.32% |
| 2002 Q4 | 182.01 Thousand USD | 21.3% |
| 2002 Q3 | 150.05 Thousand USD | -31.13% |
| 2002 Q2 | 217.88 Thousand USD | 154.99% |
| 2001 Q2 | 5809.00 USD | -74.32% |
| 2001 Q3 | 30.69 Thousand USD | 428.32% |
| 2001 Q4 | 135.71 Thousand USD | 342.21% |
| 2001 FY | 321.02 Thousand USD | -65.23% |
| 2001 Q1 | 22.62 Thousand USD | -78.8% |
| 2000 Q3 | 185.9 Thousand USD | -79.19% |
| 2000 FY | 923.37 Thousand USD | -44.69% |
| 2000 Q2 | 893.2 Thousand USD | 461.47% |
| 2000 Q1 | -247.1 Thousand USD | -279.81% |
| 2000 Q4 | 106.68 Thousand USD | -42.61% |
| 1999 FY | 1.66 Million USD | -73.2% |
| 1999 Q4 | 137.42 Thousand USD | -1.74% |
| 1999 Q3 | 139.85 Thousand USD | -71.59% |
| 1999 Q2 | 492.33 Thousand USD | 98.27% |
| 1999 Q1 | 248.31 Thousand USD | -45.89% |
| 1998 Q1 | 2.35 Million USD | -0.21% |
| 1998 Q4 | 458.93 Thousand USD | -2.31% |
| 1998 Q3 | 469.77 Thousand USD | 556.42% |
| 1998 FY | 6.22 Million USD | 183.09% |
| 1998 Q2 | 71.56 Thousand USD | -96.96% |
| 1997 Q1 | 700 Thousand USD | 250.0% |
| 1997 Q2 | 900 Thousand USD | 28.57% |
| 1997 Q3 | 1.45 Million USD | 61.18% |
| 1997 Q4 | 2.35 Million USD | 62.37% |
| 1997 FY | 2.2 Million USD | 22.22% |
| 1996 Q2 | 800 Thousand USD | 33.33% |
| 1996 Q3 | 500 Thousand USD | -37.5% |
| 1996 FY | 1.8 Million USD | 0.0% |
| 1996 Q4 | 200 Thousand USD | -60.0% |
| 1996 Q1 | 600 Thousand USD | 50.0% |
| 1995 Q3 | 200 Thousand USD | 0.0% |
| 1995 Q4 | 400 Thousand USD | 100.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 181.288% |
| Cerus Corporation | 86.4 Million USD | 97.049% |
| OrthoPediatrics Corp. | 111.25 Million USD | 97.708% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -244.815% |
| Talis Biomedical Corporation | 371 Thousand USD | -587.332% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | 69.169% |
| Inogen, Inc. | 126.69 Million USD | 97.987% |
| Spectral AI, Inc. | 7.88 Million USD | 67.64% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 138.683% |
| CVRx, Inc. | 33.03 Million USD | 92.282% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -4080.328% |
| Orthofix Medical Inc. | 486.27 Million USD | 99.476% |
| Venus Concept Inc. | 52.16 Million USD | 95.112% |
| Bioventus Inc. | 328.19 Million USD | 99.223% |
| BrainsWay Ltd. | 23.09 Million USD | 88.957% |
| Envoy Medical, Inc. | -473 Thousand USD | 639.112% |
| electroCore, Inc. | 13.22 Million USD | 80.72% |
| IceCure Medical Ltd | 1.3 Million USD | -96.154% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 142.149% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 5487.02% |
| MaxCyte, Inc. | 36.54 Million USD | 93.022% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -458.577% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2897.884% |
| PAVmed Inc | -3.96 Million USD | 164.264% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 146.49% |
| RxSight, Inc. | 53.76 Million USD | 95.257% |
| Sight Sciences, Inc. | 69.17 Million USD | 96.314% |
| SI-BONE, Inc. | 109.42 Million USD | 97.67% |
| TELA Bio, Inc. | 40.11 Million USD | 93.643% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 83.968% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 98.322% |
| LivaNova PLC | 771.25 Million USD | 99.669% |
| 908 Devices Inc. | 25.32 Million USD | 89.93% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 99.178% |
| Nemaura Medical Inc. | -1.47 Million USD | 272.718% |
| NeuroPace, Inc. | 48.12 Million USD | 94.701% |
| LENSAR, Inc. | 21.1 Million USD | 87.919% |
| Apyx Medical Corporation | 14.12 Million USD | 81.943% |
| Cutera, Inc. | 41.49 Million USD | 93.855% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 86.187% |
| BioSig Technologies, Inc. | 18 Thousand USD | -14066.667% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 97.526% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 81.269% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.713% |
| Axonics, Inc. | 274.55 Million USD | 99.071% |
| Outset Medical, Inc. | 29 Million USD | 91.207% |
| IRIDEX Corporation | 21.8 Million USD | 88.307% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 96.411% |
| IRadimed Corporation | 50.15 Million USD | 94.916% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -788.502% |
| INVO Bioscience, Inc. | 1.08 Million USD | -134.777% |
| Telesis Bio, Inc. | 16.95 Million USD | 84.956% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 97.739% |
| Varex Imaging Corporation | 256.9 Million USD | 99.007% |
| Quipt Home Medical Corp. | 163.84 Million USD | 98.444% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 728.079% |
| Pulmonx Corporation | 50.75 Million USD | 94.976% |
| Dynatronics Corporation | 7.63 Million USD | 66.601% |
| Modular Medical, Inc. | -768 Thousand USD | 432.031% |
| ReShape Lifesciences Inc. | 5.54 Million USD | 54.037% |
| Semler Scientific, Inc. | 61.2 Million USD | 95.833% |
| InMode Ltd. | 411.34 Million USD | 99.38% |
| Bruker Corporation | 1.51 Billion USD | 99.832% |
| Cytosorbents Corporation | 22.39 Million USD | 88.612% |
| DexCom, Inc. | 2.28 Billion USD | 99.889% |
| Align Technology, Inc. | 2.71 Billion USD | 99.906% |
| Viveve Medical, Inc. | 620 Thousand USD | -311.29% |
| ZimVie Inc. | 290.38 Million USD | 99.122% |
| Movano Inc. | -158 Thousand USD | 1713.924% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 97.67% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -2897.884% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 99.306% |
| Profound Medical Corp. | 4.51 Million USD | 43.509% |
| Insulet Corporation | 1.15 Billion USD | 99.78% |
| enVVeno Medical Corporation | -546 Thousand USD | 567.033% |
| Surmodics, Inc. | 93.05 Million USD | 97.26% |
| iCAD, Inc. | 14.53 Million USD | 82.457% |
| Nuwellis, Inc. | 4.98 Million USD | 48.826% |
| Biotricity, Inc. | 8.35 Million USD | 69.484% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 99.231% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 810.194% |
| InspireMD, Inc. | 1.8 Million USD | -41.118% |
| PAVmed Inc. | -3.96 Million USD | 164.264% |
| BIOLASE, Inc. | 16.72 Million USD | 84.752% |
| Beyond Air, Inc. | -1.3 Million USD | 295.103% |
| FONAR Corporation | 45.14 Million USD | 94.351% |
| AxoGen, Inc. | 127.87 Million USD | 98.006% |
| Vivani Medical, Inc. | -357 Thousand USD | 814.286% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 98.693% |
| Inari Medical, Inc. | 434.56 Million USD | 99.413% |
| UFP Technologies, Inc. | 112.22 Million USD | 97.728% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -20269.039% |
| Tenon Medical, Inc. | 1.24 Million USD | -105.479% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 3248.148% |
| Co-Diagnostics, Inc. | 2.62 Million USD | 2.934% |
| AdaptHealth Corp. | 479.56 Million USD | 99.468% |
| Sintx Technologies, Inc. | 1.84 Million USD | -38.361% |
| NanoVibronix, Inc. | 1.53 Million USD | -65.908% |
| Quanterix Corporation | 70.64 Million USD | 96.39% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 728.079% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 81.863% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 95.169% |
| TransMedics Group, Inc. | 154.09 Million USD | 98.345% |
| ReWalk Robotics Ltd. | 4.45 Million USD | 42.735% |
| NeuroMetrix, Inc. | 3.94 Million USD | 35.401% |
| Hyperfine, Inc. | 4.75 Million USD | 46.395% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 97.616% |
| Biomerica, Inc. | 611 Thousand USD | -317.349% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 93.883% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 426.523% |
| Silk Road Medical, Inc | 127.08 Million USD | 97.993% |